
Even as the science behind the new therapies is getting established, payers are preparing for their extraordinary cost

Even as the science behind the new therapies is getting established, payers are preparing for their extraordinary cost

Broader capabilities for refrigerated or cryogenic transport of cellular materials

Signs up Bayer Health for pulmonary hypertension and MS

Nov. 27, 2018, was to be a red-letter day in the 10-year program to implement an end-to-end pharma traceability system. Did industry meet the deadline?

Programs provide copay and other financial assistance

Field trial results to be unveiled at upcoming meeting

Partnership with Dacos A/S; FDA will look closer at cellular and genetic therapies

Spending on drug promotion rose—but not at the rate of pharma sales growth

Sandoz and Pear Therapeutics tackle opioid use disorder

Strengthening a leading player in track-and-trace packaging technology


List includes 25 orphan drugs; there were also seven additional biosimilars

Flu activity is “elevated” nationally; Walgreens sees a hotspot in Nebraska

Nearly a million US citizens live with HIV, a virus that still lacks a curative therapy

Cellular and genetic therapies (CGTs) developers are struggling to build capacity

Oncology represents half of the dollar volume of HDA-member sales

Pfizer’s Ibrance was the star performer from the class of 2015 FDA approvals

Action consolidates leading courier companies with larger freight forwarders

Sales volume handled by primary wholesaler/distributors seems to be declining

The carbon footprint of shipping alternatives is also becoming a competitive issue

$360-million settlement involved assistance funneled through a charity

HFAP builds out from its hospital-accreditation business

New Cardinal Health survey sees the profession adjusting to value-based care

Now a national provider, Senderra’s new dispensing location is in Morrisville, NC

More-complete information is desirable on some applications

Already-built Las Colinas facility will be the global headquarters in April 2019

New survey finds weaknesses in patient privacy, funding oversight

Drug abuse and suicide rates point to the need to address mental health

AI tools enable Verantos to provide more accurate RWE data for FDA approvals